IRIS
SANTORO, Domenico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 22.321
NA - Nord America 21.998
AS - Asia 10.849
SA - Sud America 4.188
Continente sconosciuto - Info sul continente non disponibili 829
AF - Africa 328
OC - Oceania 22
Totale 60.535
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.215
RU - Federazione Russa 10.272
SG - Singapore 4.446
IT - Italia 3.716
BR - Brasile 3.528
CN - Cina 2.889
IE - Irlanda 2.302
SE - Svezia 1.931
HK - Hong Kong 1.104
DE - Germania 932
VN - Vietnam 731
FR - Francia 678
UA - Ucraina 516
FI - Finlandia 471
NL - Olanda 413
GB - Regno Unito 408
IN - India 401
CA - Canada 323
BD - Bangladesh 300
AR - Argentina 238
PL - Polonia 209
MX - Messico 140
TR - Turchia 124
EC - Ecuador 104
IQ - Iraq 102
JP - Giappone 97
ZA - Sudafrica 92
ID - Indonesia 88
CO - Colombia 86
ES - Italia 77
VE - Venezuela 71
AT - Austria 69
PK - Pakistan 66
UZ - Uzbekistan 65
BE - Belgio 61
CR - Costa Rica 55
MA - Marocco 52
IL - Israele 50
JM - Giamaica 47
CL - Cile 45
CZ - Repubblica Ceca 44
PY - Paraguay 41
AE - Emirati Arabi Uniti 33
MY - Malesia 33
PE - Perù 32
AZ - Azerbaigian 31
SA - Arabia Saudita 31
GT - Guatemala 30
KE - Kenya 30
NP - Nepal 30
PH - Filippine 30
HN - Honduras 28
NI - Nicaragua 28
RO - Romania 28
EG - Egitto 26
TT - Trinidad e Tobago 26
CI - Costa d'Avorio 25
JO - Giordania 25
TN - Tunisia 25
UY - Uruguay 25
DZ - Algeria 23
LT - Lituania 23
SV - El Salvador 23
AL - Albania 22
CH - Svizzera 22
GP - Guadalupe 22
GR - Grecia 21
KZ - Kazakistan 19
DO - Repubblica Dominicana 18
KG - Kirghizistan 18
BO - Bolivia 16
EE - Estonia 16
IR - Iran 15
PR - Porto Rico 15
AU - Australia 14
LB - Libano 14
SC - Seychelles 14
CW - ???statistics.table.value.countryCode.CW??? 13
BG - Bulgaria 12
GE - Georgia 11
OM - Oman 11
PS - Palestinian Territory 11
ET - Etiopia 10
EU - Europa 10
RS - Serbia 10
KR - Corea 9
AM - Armenia 8
LV - Lettonia 8
NO - Norvegia 8
PA - Panama 8
SY - Repubblica araba siriana 8
BY - Bielorussia 7
CY - Cipro 7
NZ - Nuova Zelanda 7
PT - Portogallo 7
SN - Senegal 7
TH - Thailandia 7
BH - Bahrain 6
HU - Ungheria 6
MD - Moldavia 6
Totale 59.627
Salva come PNG Salva come JPEG
Città #
Ashburn 3.305
Moscow 3.118
Dublin 2.293
Singapore 2.232
Dallas 2.138
Chandler 1.582
San Jose 1.322
Jacksonville 1.106
Hong Kong 1.094
Beijing 1.010
Nyköping 959
Council Bluffs 741
The Dalles 566
Los Angeles 438
Princeton 429
Medford 393
Lauterbourg 387
Messina 381
Cambridge 361
Dearborn 355
Des Moines 324
New York 307
São Paulo 291
Oude Meer 280
Boardman 260
Ann Arbor 243
Rome 241
Buffalo 229
Ho Chi Minh City 228
Munich 219
Milan 217
Santa Clara 186
Warsaw 179
Hanoi 164
Hyderabad 149
Tianjin 133
Frankfurt am Main 121
San Mateo 121
Houston 117
Redondo Beach 115
Rio de Janeiro 108
Woodbridge 104
Jinan 102
Belo Horizonte 101
Guangzhou 100
Orem 100
Wilmington 95
Phoenix 94
Brooklyn 84
Tokyo 84
North Bergen 82
Montreal 75
Turku 75
Bremen 73
Seattle 72
Brasília 68
Palermo 68
Catania 67
Denver 67
Shenyang 66
Atlanta 63
Naples 61
Chicago 59
Shanghai 58
Tashkent 58
Columbus 57
Brussels 56
Nanjing 56
Nuremberg 56
Curitiba 55
Turin 53
Chennai 52
Pune 52
Bologna 51
Johannesburg 49
Ottawa 49
Stockholm 49
Florence 48
Porto Alegre 46
London 45
Mexico City 45
San José 45
Helsinki 44
Campinas 43
Hebei 41
Vienna 41
Baghdad 40
San Francisco 39
Genova 38
Amsterdam 37
Boston 36
Lancaster 36
Manchester 36
Poplar 36
Guayaquil 35
Toronto 35
Hangzhou 34
Norwalk 34
Shenzhen 33
Zhengzhou 33
Totale 31.853
Salva come PNG Salva come JPEG
Nome #
La sindrome MIA ( malnutrizione-infiammazione-aterosclerosi nel paziente uremico 1.544
Amiloidosi renale e fibrosi cistica: Ruolo della terapia con colchicina 801
Terapia nutrizionale nell'IRC in fase conservativa: suggerimenti di pratica clinica e di applicazione delle linee guida 557
Henoch-Schonlein purpura associated with acetaminophen and codeine. 401
Urine therapy through the centuries. 388
Impotence in the XVIII century as described by Gian Pietro Fusanacci and Tommaso Eduardo Beatty 301
Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study 295
Circulating sclerostin and Dickkopf-1 correlate with vascular calcifications in non-dialysis chronic kidney disease 274
[Long-term outcome of renal function in women with preeclampia and pregestational diabetes] 267
[Periorbital purpura: a pathognomonic but late sign of AL amyloidosis] / Porpora periorbitaria: un segnale patognomonico ma tardivo di amiloidosi AL 257
[Management of hyperphosphatemia in patients with chronic kidney disease] 243
[Lupus Nephritis and Enteritis, a dual simultaneous involvement with Arteriolar Thrombosis] 242
[From hyponatremia to tolvaptan] 242
[Complement factor B mutation in atypical hemolytic uremic syndrome. Rare cause of rare disease] 240
Association of higher advanced oxidation protein  products (AOPPs) levels in patients with diabetic  and hypertensive nephropathy 238
Metformin-related lactic acidosis: is it a myth or an underestimated reality? 236
[Renal and extra-renal involvement in sclerodermia.] 233
A new approach to the evaluation of hyperphosphatemia in chronic kidney disease 230
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens 226
Association of VDR gene polymorphisms with heart disease in chronic kidney disease patients 223
Therapy of Hyperhomocysteinemia in Hemodialysis Patients: Effects of Folates and N-Acetylcysteine 220
[Long-term outcome of renal function in women with preeclampia and pregestational diabetes] 220
Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure 219
Sclerostin levels in uremic patients: a link between bone and vascular disease 217
Flavocoxid, a Natural Antioxidant, Protects Mouse Kidney from Cadmium-Induced Toxicity. 217
ACCIDENTAL DISCOVERY OF LUNG METATSTASES FROM DIFFERENTIATED THYROID CANCER BY TC-99M PERTECHNETATE SCAN IN A PATIENT WITH SECONDARY HYPERPARATHYROIDISM 215
Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease 213
Auxin induces cell proliferation in an experimental model of mammalian renal tubular epithelial cells 211
History of L-carnitine: Implications for renal disease 208
Defense mechanisms in hemodialysis-dependent patients 207
Sevalamer Hydrochloride, Sevelamer Carbonate and Lanthanum Carbonate: In Vitro and In Vivo Effects on Gastric Environment 206
Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study 205
Role of Paricalcitol in Modulating the Immune Response in Patients with Renal Disease 204
Association of parathyroid carcinoma and thyroid disorders: A clinical review 204
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy 202
Antiosteoporotic activity of genistein aglycone in postmenopausal women: Evidence from a post-hoc analysis of a multicenter randomized controlled trial 202
Autoimmune thyroiditis and glomerulopathies 201
The Myth of Water and Salt: From Aquaretics to Tenapanor 200
Correction to: Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 200
An update on calcium metabolism alterations and cardiovascular risk in patients with chronic kidney disease: questions, myths and facts. 197
In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: A population-based study 196
Chronic Kidney Disease Management in General Practice: A Focus on Inappropriate Drugs Prescriptions 196
C3 glomerulopathy in cystic fibrosis: a casereport 194
Adaptation of the Mishel Uncertainty of Illness Scale (MUIS) for chronic patients in Italy 193
Delayed graft function and chronic allograft nephropathy: Diagnostic and prognostic role of neutrophil gelatinase-associated lipocalin 193
ACCUMULO DI TECNEZIO IN METASTASI POLMONARI DA CARCINOMA DIFFERENZIATO TIROIDEO (CDT): UNA RARA EVENIENZA 192
Endothelial dysfunction in chronic renal failure. 191
Accidental discovery of lung metastases from differentiated thyroid cancer by 99mTc sodium pertechnetate scan in a patient with secondary hyperparathyroidism 190
Beneficial effects of oral pure caffeine on oxidative stress 190
Stress ossidativo in una popolazione di ipertesi e nefropatici: utilità del dosaggio dell’AOPP 187
Acetate-free biofiltration to remove fibroblast growth factor 23 in hemodialysis patients: a pilot study 186
ALTERAZIONI RENALI IN UN CASO DI CRIOGLOBULINEMIA MISTA DI TIPO 2 IN UN PAZIENTE AFFETTO DA LINFOMA CON CELLULE B. 185
A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy 184
Hypernatraemia and low eGFR at hospitalization in COVID-19 patients: a deadly combination 184
Kidney disease and psoriasis: novel evidences beyond old concepts 182
Absorbable phosphate in medication 182
Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report 182
The concept of the urine test and specific reaction of the urine in various diseases according to Enrico Cauchi - member of the medical council of Malta (1933) 181
Case report on pathogenetic link between gluten and IgA nephropathy 181
A Keynesian perspective on the health economics of kidney transplantation would strengthen the value of the whole organ donation and transplantation service 180
Convective Dialysis Reduces Mortality Risk: Results From a Large Observational, Population-Based Analysis 178
Impotence in the 18th and 19th century: concepts of etiology and approaches to therapy. 176
A longitudinal study of sleep disorders in early-stage chronic kidney disease 176
A prospective, multicenter, randomized, controlled study: the Correction of Metabolic Acidosis with Use of Bicarbonate in Chronic Renal Insufficiency (UBI) Study 176
Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis 175
Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease 174
Thyroid hormone autoantibodies: Are they a better marker to detect early thyroid damage in patients with hematologic cancers receiving tyrosine kinase inhibitor or immunoregulatory drug treatments? 174
Opposite actions of urotensin II and relaxin-2 on cellular expression of fibronectin in renal fibrosis: A preliminary experimental study 173
Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents? 173
Negative Emotions in End-Stage Renal Disease: Are Anxiety Symptoms Related to Levels of Circulating Catecholamines? 171
The Management of Diabetes Mellitus in Patients with Chronic Kidney Disease: A Population-Based Study in Southern Italy 170
Vitamin D receptor polymorphism in chronic kidney disease patients with complicated cardiovascular disease 170
Kidney biopsy in type 2 diabetic patients: Critical reflections on present indications and diagnostic alternatives 169
Vascular access for hemodialysis: current perspectives 168
A best-practice position statement on pregnancy after kidney transplantation: focusing on the unsolved questions. The Kidney and Pregnancy Study Group of the Italian Society of Nephrology 168
[From scientific evidence to clinical recommendations: outlooks and challenges for the SIN (Italian Society of Nephrology)] 168
Pain in Renal Disease. 167
Renoprotective effect of erythropoietin in zebrafish after administration of gentamicin: an immunohistochemical study for β-catenin and c-kit expression 167
Autonomic dysfunction in uremia 166
[Nutritional diet therapy in the management of the patient with Chronic Kidney Disease in advanced phase to delay the beginning and reduce the frequency of dialysis. An option also in the pre-emptive transplant program] 166
Caso clinico di una bambina con lichen follicolare e sindrome nefrosica 165
Interplay of vitamin D, erythropoiesis, and the renin-angiotensin system 165
Cystic Fibrosis: A Risk Condition for Renal Disease 165
Monocyte to HDL ratio: a novel marker of resistant hypertension in CKD patients 164
Nephro-oncology: a link in evolution 164
Nutritional treatment of advanced CKD: twenty consensus statements 164
Histologic and clinical factors associated with kidney outcomes in IgA Vasculitis Nephritis 164
Analisi dei costi dell’eritropoietina in dialisi nella regione sicilia 163
Dual αvβ3 and αvβ5 blockade attenuates fibrotic and vascular alterations in a murine model of systemic sclerosis 163
Indole-3-acetic acid correlates with monocyte-to-high-density lipoprotein (HDL) ratio (MHR) in chronic kidney disease patients 163
Correlation between Hyperkalemia and the Duration of Several Hospitalizations in Patients with Chronic Kidney Disease 162
A Delphi consensus panel on nutritional therapy in chronic kidney disease 162
EFFECTIVENESS OF L-CARNITINE THERAPY IN UREMIC ANEMIA 161
Choice of dialysis treatment and type of medical unit (private vs public): application of a recursive bivariate probit 161
Dense deposit disease in a child with febrile sore throat 161
Semaphorin 3A serum levels are influenced by haemodialysis: what clinical significance? 160
Copy number variant analysis and genome-wide association study identify loci with large effect for vesicoureteral reflux 160
Gender differences in new hypoglycemic drug effects on renal outcomes: a systematic review 160
Compliance ed emozioni in una popolazione di emodializzati 159
SCLEROSTIN AND DICKKOPF-1 CORRELATE WITH VASCULAR CALCIFICATIONS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 159
Totale 22.025
Salva come PNG Salva come JPEG
Categoria #
all - tutte 208.216
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 208.216
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.496 0 0 0 0 109 51 203 149 128 490 402 964
2022/20236.667 558 523 309 469 508 639 103 386 2.806 75 201 90
2023/20242.053 175 288 152 146 170 368 41 129 33 204 59 288
2024/20258.846 138 61 193 465 385 349 333 1.919 2.173 563 840 1.427
2025/202627.092 1.273 1.779 2.548 2.137 2.311 5.396 3.074 3.128 3.015 1.084 694 653
2026/20275.592 790 1.353 1.322 1.899 228 0 0 0 0 0 0 0
Totale 60.535